The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment. [electronic resource]
Producer: 20181012Description: 1882-1883 p. digitalISSN:- 1538-7836
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.